LT3601B - Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof - Google Patents

Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof Download PDF

Info

Publication number
LT3601B
LT3601B LTIP829A LTIP829A LT3601B LT 3601 B LT3601 B LT 3601B LT IP829 A LTIP829 A LT IP829A LT IP829 A LTIP829 A LT IP829A LT 3601 B LT3601 B LT 3601B
Authority
LT
Lithuania
Prior art keywords
propyl
alkyl
radical
morpholino
amino
Prior art date
Application number
LTIP829A
Other languages
English (en)
Lithuanian (lt)
Inventor
Eric Cossement
Jean Gobert
Roland Boydens
Jacques Mathieu
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of LTIP829A publication Critical patent/LTIP829A/xx
Publication of LT3601B publication Critical patent/LT3601B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
LTIP829A 1988-08-16 1993-08-03 Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof LT3601B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819493A GB8819493D0 (en) 1988-08-16 1988-08-16 2-amino-4-morpholino-6-propyl-1 3 5-triazines

Publications (2)

Publication Number Publication Date
LTIP829A LTIP829A (en) 1995-02-27
LT3601B true LT3601B (en) 1995-12-27

Family

ID=10642235

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP829A LT3601B (en) 1988-08-16 1993-08-03 Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof

Country Status (28)

Country Link
US (1) US4956367A (xx)
EP (1) EP0356413B1 (xx)
JP (1) JPH02108675A (xx)
KR (1) KR0136108B1 (xx)
AT (1) ATE72241T1 (xx)
AU (1) AU614247B2 (xx)
CA (1) CA1317944C (xx)
CY (1) CY1709A (xx)
DE (1) DE68900794D1 (xx)
DK (1) DK171698B1 (xx)
ES (1) ES2038849T3 (xx)
FI (1) FI102065B1 (xx)
GB (1) GB8819493D0 (xx)
GR (1) GR3004267T3 (xx)
HK (1) HK95693A (xx)
HU (1) HUT58087A (xx)
IE (1) IE61205B1 (xx)
IL (1) IL91243A (xx)
LT (1) LT3601B (xx)
MY (1) MY105008A (xx)
NO (1) NO179206C (xx)
NZ (1) NZ230290A (xx)
PL (2) PL161161B1 (xx)
PT (1) PT91438B (xx)
RU (3) RU1806142C (xx)
SG (1) SG27893G (xx)
UA (1) UA11064A (xx)
ZA (1) ZA896222B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
IT1240690B (it) * 1990-04-30 1993-12-17 Ciba Geigy Ag Composti piperdin-triazinici atti all'impiego come stabilizzanti per materiali organici
GB9116039D0 (en) * 1991-07-25 1991-09-11 Ucb Sa Substituted cyclopropylamino-1,3,5-triazines

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4969688A (xx) 1972-11-02 1974-07-05

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549757A (en) * 1968-03-27 1970-12-22 Shell Oil Co Use of 2-morpholino - 4 - amino-6-substituted-s-triazines for inducing depressant effects in animals
FR2262512A1 (en) * 1974-03-01 1975-09-26 Synthelabo 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4969688A (xx) 1972-11-02 1974-07-05

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALAIN PLATEL, ROGER D. PORSOLT: "Habituation of exploratory activity in mice: A screening test for memory enhancing drugs", PSYCHOPHARMACOLOGY, 1982, pages 346 - 352
GLICK, S.D.; ZIMMERBERG, B.: "Amnesic effects of scopolamine", BEHAVIORAL BIOLOGY, 1972, pages 245 - 254
P.ETEVENON: "Elektroencefalografija su ESM. Kiekybinė analizė ir statistika."
U. SCHINDLER, D. K. RUSH ANDS. FIELDING: "Nootropic drugs: Animal models for studying effects on cognition", DRUG DEVELOPMENT RESEARC, 1984, pages 567 - 576, XP001050360, DOI: doi:10.1002/ddr.430040510

Also Published As

Publication number Publication date
DK398189D0 (da) 1989-08-14
KR0136108B1 (ko) 1998-04-25
EP0356413A1 (fr) 1990-02-28
AU3991789A (en) 1990-04-05
HK95693A (en) 1993-09-24
ZA896222B (en) 1990-05-30
RU1822403C (ru) 1993-06-15
ES2038849T3 (es) 1993-08-01
FI102065B (fi) 1998-10-15
LTIP829A (en) 1995-02-27
KR900003165A (ko) 1990-03-23
US4956367A (en) 1990-09-11
DE68900794D1 (en) 1992-03-12
DK398189A (da) 1990-02-17
NZ230290A (en) 1991-10-25
DK171698B1 (da) 1997-03-24
FI102065B1 (fi) 1998-10-15
PL161161B1 (pl) 1993-05-31
NO179206C (no) 1996-08-28
HUT58087A (en) 1992-01-28
CY1709A (en) 1994-01-14
IL91243A0 (en) 1990-03-19
GR3004267T3 (xx) 1993-03-31
NO893279L (no) 1990-02-19
UA11064A (uk) 1996-12-25
ATE72241T1 (de) 1992-02-15
IE892619L (en) 1990-02-16
FI893714A (fi) 1990-02-17
PL161591B1 (pl) 1993-07-30
IL91243A (en) 1995-05-26
NO179206B (no) 1996-05-20
RU1806142C (ru) 1993-03-30
NO893279D0 (no) 1989-08-15
MY105008A (en) 1994-07-30
PT91438A (pt) 1990-03-08
RU1838312C (ru) 1993-08-30
CA1317944C (en) 1993-05-18
SG27893G (en) 1993-06-25
JPH02108675A (ja) 1990-04-20
IE61205B1 (en) 1994-10-19
PT91438B (pt) 1995-05-04
FI893714A0 (fi) 1989-08-07
GB8819493D0 (en) 1988-09-21
EP0356413B1 (fr) 1992-01-29
AU614247B2 (en) 1991-08-22

Similar Documents

Publication Publication Date Title
RU2095353C1 (ru) Замещенные циклопропиламино-1,3,5-триазины, их оптические изомеры, рацемические смеси или их соли присоединения нетоксичных фармацевтически приемлемых кислот, проявляющие фармакологическую активность, способ их получения и фармацевтическая композиция на их основе
DE69532811T2 (de) Heterocyclische Derivative und Arzneimittel
Jacobsen et al. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma
KR0137660B1 (ko) 노화와 치매증에 관련된 인식 및 행동장애 치료제
PT96228A (pt) Processo para a preparacao de composicoes de analogos da benzodiazepina para o tratamento da reaccao de panico e para inducao directa da analgesia e respectivos metodos de tratamento
PL134903B1 (en) Method of obtaining novel 2-/4-/diphenylomethylo/-1-piperazinylo/acetamides
CS240954B2 (en) Preparation method of 1,2-dihydropyridines
FR2804113A1 (fr) Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
PL147387B1 (en) Method of obtaining /r/-alpha-ethyl-2-keto-pyrolidinacetamide
JP2003300875A (ja) インターロイキン１２抑制剤
LT3601B (en) Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof
JPH0723365B2 (ja) フエノキシアルキルまたはチオフエノキシアルキル側鎖を有する新規ピペラジンカルボキシアミド化合物
HUT70148A (en) Isoquinolone derivatives as techykinin receptor antagonists, process for producing thereof and pharmaceutical compositions comprising them
HU222246B1 (hu) Piperidin-karbaminsav-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
DE69210229T2 (de) Dihydrochinolin NMDA Antagonisten
DD298915A5 (de) Verfahren zur herstellung von pharmakologisch wirksamen 3-aminopyrrolen
HU211494A9 (en) Benz[e]indene derivatives

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19990803